Table 1.
Study Group | N | Age (Years) (Mean ± SD) | LOCS | BSCVA (logMAR) (Mean ± SD) |
---|---|---|---|---|
MoG | 30 | 57.4 ± 7.4 | Stage 2 | 0.62 ± 0.07 |
MfG | 30 | 60.3 ± 8.3 | Stage 2 | 0.55 ± 0.11 |
HmG | 30 | 57.0 ± 8.8 | Stage 2 | 0.54 ± 0.09 |
PmG | 30 | 57.9 ± 9.3 | Stage 2 | 0.60 ± 0.06 |
P-values | ΝΑ | 0.12 | NA | 0.18 |
Abbreviations: BSCVA, best spectacle-corrected visual acuity (logMAR); HmG, Hybrid Monovision Group; LOCS, Lens Opacities Classification System; MfG, Multifocal Lens Group; MoG, Monovision Group; N, number of patients; NA, not applicable; PmG, Premium Monovision Group; SD, standard deviation.